Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Exelixis News Editors

News Widget

Display the Exelixis news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Exelixis News

News on Exelixis (Ticker: EXEL) continually updated from thousands of sources around the net.

20 hrs ago | Freshnews

Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival...

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer .

Comment?

Related Topix: Startups, South San Francisco, CA, Medicine, Cancer, Health, Prostate Cancer

20 hrs ago | Freshnews

Exelixis Completes Submission of New Drug Application for...

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. today announced that it has completed the filing of its rolling New Drug Application with the U.S. Food and Drug Administration for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .

Comment?

Related Topix: Startups, Healthcare Law, Law, Food and Drug Administration, Thyroid Cancer, Health

Wed May 16, 2012

Freshnews

Reminder: Exelixis Announces Data Presentations, Webcast of Investor...

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. reiterated its slate of activities in conjunction with the 2012 American Society of Clinical Oncology Annual Meeting, which will be held June 1-5, 2012, in Chicago, Illinois.

Comment?

Related Topix: Startups

Thu May 10, 2012

Freshnews

Exelixis Announces May 17th Webcast of Presentation at the Bank of...

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. announced today that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will present at the Bank of America Merrill Lynch 2012 Health Care Conference at 3:00 p.m. EDT / noon PDT on Thursday, May 17, 2012, in Las Vegas.

Comment?

Related Topix: Startups, South San Francisco, CA

Tue May 08, 2012

Seeking Alpha

For Dendreon There's A Little Light, But A Lot Of Tunnel

Volatile biotech Dendreon has been a painful lesson for some investors that there's a big difference between good technology and a good stock.

Comment?

Related Topix: Dendreon, Oncology, Medicine, Startups

Thu May 03, 2012

Seeking Alpha

Exelixis's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Good day, Ladies and Gentlemen, and welcome to the First Quarter 2012 Exelixis' Financial Results Conference Call.

Comment?

Related Topix: Startups, Law, Healthcare Law

Freshnews

Exelixis Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. today announced a broad expansion of the cabozantinib development program under a Cooperative Research and Development Agreement with the National Cancer Institute's Cancer Therapy Evaluation Program , with the approval of the initial program of 12 proposed clinical trials under the agreement.

Comment?

Related Topix: Startups, South San Francisco, CA

Wed May 02, 2012

Freshnews

Exelixis Announces May 8th Webcast of Presentation at the Deutsche...

SOUTH SAN FRANCISCO, Calif. -- -- Exelixis, Inc. announced today that Frank Karbe, the company's executive vice president and chief financial officer, will present at the upcoming Deutsche Bank Securities 37th Annual Health Care Conference at 4:50 p.m. EDT / 1:50 p.m. PDT on Tuesday, May 8, 2012, in Boston.

Comment?

Related Topix: Startups, Banking, Deutsche Bank AG, Financial Services, South San Francisco, CA

Los Angeles Jobs

Also on Topix